SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-048379
Filing Date
2022-04-21
Accepted
2022-04-21 16:05:21
Documents
1
Group Members
KOH, BONGSHAH, NIMISHVENROCK HEALTHCARE CAPITAL PARTNERS EG, L.P.VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.VHCP CO-INVESTMENT HOLDINGS II, LLCVHCP CO-INVESTMENT HOLDINGS III, LLCVHCP MANAGEMENT EG, LLCVHCP MANAGEMENT II, LLCVHCP MANAGEMENT III, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2213208d1_sc13g.htm SC 13G 298196
  Complete submission text file 0001104659-22-048379.txt   300124
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Subject) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91005 | Film No.: 22841437
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 BRYANT PARK 23RD FLOOR NEW YORK NY 10018
Business Address 7 BRYANT PARK 23RD FLOOR NEW YORK NY 10018 650 475 3734
Venrock Healthcare Capital Partners II, L.P. (Filed by) CIK: 0001602264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G